Global Age Related Macular Degeneration (AMD) Market Growth (Status and Outlook) 2021-2026
According to this latest study, the 2020 growth of Age Related Macular Degeneration (AMD) will have significant change from previous year. By the most conservative estimates of global Age Related Macular Degeneration (AMD) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1282.4 million in 2019. Over the next five years the Age Related Macular Degeneration (AMD) market will register a 4.9% CAGR in terms of revenue, the global market size will reach US$ 1551.8 million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Age Related Macular Degeneration (AMD) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Wet AMD
Dry AMD
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Men
Woman
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bayer
F. HoffmannLa Roche
Regeneron
Novartis
Valeant
Pfizer
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Age Related Macular Degeneration (AMD) Market Size 2016-2026
2.1.2 Age Related Macular Degeneration (AMD) Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Age Related Macular Degeneration (AMD) Segment by Type
2.2.1 Wet AMD
2.2.2 Wet AMD
2.3 Age Related Macular Degeneration (AMD) Market Size by Type
2.3.1 Global Age Related Macular Degeneration (AMD) Market Size CAGR by Type
2.3.2 Global Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2016-2021)
2.4 Age Related Macular Degeneration (AMD) Segment by Application
2.4.1 Men
2.4.2 Woman
2.5 Age Related Macular Degeneration (AMD) Market Size by Application
2.5.1 Global Age Related Macular Degeneration (AMD) Market Size CAGR by Application
2.5.2 Global Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2016-2021)
3 Global Age Related Macular Degeneration (AMD) by Players
3.1 Age Related Macular Degeneration (AMD) Market Size Market Share by Players
3.1.1 Global Age Related Macular Degeneration (AMD) Revenue by Players (2019-2021E)
3.1.2 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Players (2019-2021E)
3.2 Global Age Related Macular Degeneration (AMD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Age Related Macular Degeneration (AMD) by Regions
4.1 Age Related Macular Degeneration (AMD) Market Size by Regions (2016-2021)
4.2 Americas Age Related Macular Degeneration (AMD) Market Size Growth (2016-2021)
4.3 APAC Age Related Macular Degeneration (AMD) Market Size Growth (2016-2021)
4.4 Europe Age Related Macular Degeneration (AMD) Market Size Growth (2016-2021)
4.5 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Growth (2016-2021)
5 Americas
5.1 Americas Age Related Macular Degeneration (AMD) Market Size by Country (2016-2021)
5.2 Americas Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021)
5.3 Americas Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Age Related Macular Degeneration (AMD) Market Size by Region (2016-2021)
6.2 APAC Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021)
6.3 APAC Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Age Related Macular Degeneration (AMD) by Country (2016-2021)
7.2 Europe Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021)
7.3 Europe Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Age Related Macular Degeneration (AMD) by Region (2016-2021)
8.2 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021)
8.3 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Age Related Macular Degeneration (AMD) Market Forecast
10.1 Global Age Related Macular Degeneration (AMD) Forecast by Regions (2021-2026)
10.1.1 Global Age Related Macular Degeneration (AMD) Forecast by Regions (2021-2026)
10.1.2 Americas Age Related Macular Degeneration (AMD) Forecast
10.1.3 APAC Age Related Macular Degeneration (AMD) Forecast
10.1.4 Europe Age Related Macular Degeneration (AMD) Forecast
10.1.5 Middle East & Africa Age Related Macular Degeneration (AMD) Forecast
10.2 Americas Age Related Macular Degeneration (AMD) Forecast by Countries (2021-2026)
10.2.1 United States Age Related Macular Degeneration (AMD) Market Forecast
10.2.2 Canada Age Related Macular Degeneration (AMD) Market Forecast
10.2.3 Mexico Age Related Macular Degeneration (AMD) Market Forecast
10.2.4 Brazil Age Related Macular Degeneration (AMD) Market Forecast
10.3 APAC Age Related Macular Degeneration (AMD) Forecast by Region (2021-2026)
10.3.1 China Age Related Macular Degeneration (AMD) Market Forecast
10.3.2 Japan Age Related Macular Degeneration (AMD) Market Forecast
10.3.3 Korea Age Related Macular Degeneration (AMD) Market Forecast
10.3.4 Southeast Asia Age Related Macular Degeneration (AMD) Market Forecast
10.3.5 India Age Related Macular Degeneration (AMD) Market Forecast
10.3.6 Australia Age Related Macular Degeneration (AMD) Market Forecast
10.4 Europe Age Related Macular Degeneration (AMD) Forecast by Country (2021-2026)
10.4.1 Germany Age Related Macular Degeneration (AMD) Market Forecast
10.4.2 France Age Related Macular Degeneration (AMD) Market Forecast
10.4.3 UK Age Related Macular Degeneration (AMD) Market Forecast
10.4.4 Italy Age Related Macular Degeneration (AMD) Market Forecast
10.4.5 Russia Age Related Macular Degeneration (AMD) Market Forecast
10.5 Middle East & Africa Age Related Macular Degeneration (AMD) Forecast by Region (2021-2026)
10.5.1 Egypt Age Related Macular Degeneration (AMD) Market Forecast
10.5.2 South Africa Age Related Macular Degeneration (AMD) Market Forecast
10.5.3 Israel Age Related Macular Degeneration (AMD) Market Forecast
10.5.4 Turkey Age Related Macular Degeneration (AMD) Market Forecast
10.5.5 GCC Countries Age Related Macular Degeneration (AMD) Market Forecast
10.6 Global Age Related Macular Degeneration (AMD) Forecast by Type (2021-2026)
10.8 Global Age Related Macular Degeneration (AMD) Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Age Related Macular Degeneration (AMD) Product Offered
11.1.3 Bayer Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 F. HoffmannLa Roche
11.2.1 F. HoffmannLa Roche Company Information
11.2.2 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Product Offered
11.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 F. HoffmannLa Roche Main Business Overview
11.2.5 F. HoffmannLa Roche Latest Developments
11.3 Regeneron
11.3.1 Regeneron Company Information
11.3.2 Regeneron Age Related Macular Degeneration (AMD) Product Offered
11.3.3 Regeneron Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Regeneron Main Business Overview
11.3.5 Regeneron Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Age Related Macular Degeneration (AMD) Product Offered
11.4.3 Novartis Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Valeant
11.5.1 Valeant Company Information
11.5.2 Valeant Age Related Macular Degeneration (AMD) Product Offered
11.5.3 Valeant Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Valeant Main Business Overview
11.5.5 Valeant Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Age Related Macular Degeneration (AMD) Product Offered
11.6.3 Pfizer Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
...
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Age Related Macular Degeneration (AMD) Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Wet AMD
Table 3. Major Players of Dry AMD
Table 4. Age Related Macular Degeneration (AMD) Market Size CAGR by Type (2016-2021) & ($ Millions)
Table 5. Global Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2016-2021)
Table 7. Age Related Macular Degeneration (AMD) Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2016-2021)
Table 10. Global Age Related Macular Degeneration (AMD) Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Players (2019-2021E)
Table 12. Global Age Related Macular Degeneration (AMD) Key Players Head office and Products Offered
Table 13. Age Related Macular Degeneration (AMD) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Age Related Macular Degeneration (AMD) Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global Age Related Macular Degeneration (AMD) Market Size Market Share by Regions 2016-2021
Table 18. Americas Age Related Macular Degeneration (AMD) Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas Age Related Macular Degeneration (AMD) Market Size Market Share by Country (2016-2021)
Table 20. Americas Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2016-2021)
Table 22. Americas Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2016-2021)
Table 24. APAC Age Related Macular Degeneration (AMD) Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Region (2016-2021)
Table 26. APAC Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2016-2021)
Table 28. APAC Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2016-2021)
Table 30. Europe Age Related Macular Degeneration (AMD) Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Country (2016-2021)
Table 32. Europe Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2016-2021)
Table 34. Europe Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of Age Related Macular Degeneration (AMD)
Table 43. Key Application and Potential Industries of Age Related Macular Degeneration (AMD)
Table 44. Key Challenges of Age Related Macular Degeneration (AMD)
Table 45. Key Trends of Age Related Macular Degeneration (AMD)
Table 46. Global Age Related Macular Degeneration (AMD) Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global Age Related Macular Degeneration (AMD) Market Size Market Share Forecast by Regions
Table 48. Global Age Related Macular Degeneration (AMD) Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global Age Related Macular Degeneration (AMD) Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global Age Related Macular Degeneration (AMD) Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global Age Related Macular Degeneration (AMD) Market Size Market Share Forecast by Application (2021-2026)
Table 52. Bayer Details, Company Type, Age Related Macular Degeneration (AMD) Area Served and Its Competitors
Table 53. Bayer Age Related Macular Degeneration (AMD) Product Offered
Table 54. Bayer Age Related Macular Degeneration (AMD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. Bayer Main Business
Table 56. Bayer Latest Developments
Table 57. F. HoffmannLa Roche Details, Company Type, Age Related Macular Degeneration (AMD) Area Served and Its Competitors
Table 58. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Product Offered
Table 59. F. HoffmannLa Roche Main Business
Table 60. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. F. HoffmannLa Roche Latest Developments
Table 62. Regeneron Details, Company Type, Age Related Macular Degeneration (AMD) Area Served and Its Competitors
Table 63. Regeneron Age Related Macular Degeneration (AMD) Product Offered
Table 64. Regeneron Main Business
Table 65. Regeneron Age Related Macular Degeneration (AMD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Regeneron Latest Developments
Table 67. Novartis Details, Company Type, Age Related Macular Degeneration (AMD) Area Served and Its Competitors
Table 68. Novartis Age Related Macular Degeneration (AMD) Product Offered
Table 69. Novartis Main Business
Table 70. Novartis Age Related Macular Degeneration (AMD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. Novartis Latest Developments
Table 72. Valeant Details, Company Type, Age Related Macular Degeneration (AMD) Area Served and Its Competitors
Table 73. Valeant Age Related Macular Degeneration (AMD) Product Offered
Table 74. Valeant Main Business
Table 75. Valeant Age Related Macular Degeneration (AMD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. Valeant Latest Developments
Table 77. Pfizer Details, Company Type, Age Related Macular Degeneration (AMD) Area Served and Its Competitors
Table 78. Pfizer Age Related Macular Degeneration (AMD) Product Offered
Table 79. Pfizer Main Business
Table 80. Pfizer Age Related Macular Degeneration (AMD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. Pfizer Latest Developments
List of Figures
Figure 1. Age Related Macular Degeneration (AMD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Age Related Macular Degeneration (AMD) Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2016-2021)
Figure 7. Age Related Macular Degeneration (AMD) in Men
Figure 8. Global Age Related Macular Degeneration (AMD) Market: Men (2016-2021) & ($ Millions)
Figure 9. Age Related Macular Degeneration (AMD) in Woman
Figure 10. Global Age Related Macular Degeneration (AMD) Market: Woman (2016-2021) & ($ Millions)
Figure 11. Global Age Related Macular Degeneration (AMD) Market Size Market Share by Application in 2020
Figure 12. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Player in 2020
Figure 13. Global Age Related Macular Degeneration (AMD) Market Size Market Share by Regions (2016-2021)
Figure 14. Americas Age Related Macular Degeneration (AMD) Market Size 2016-2021 ($ Millions)
Figure 15. APAC Age Related Macular Degeneration (AMD) Market Size 2016-2021 ($ Millions)
Figure 16. Europe Age Related Macular Degeneration (AMD) Market Size 2016-2021 ($ Millions)
Figure 17. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size 2016-2021 ($ Millions)
Figure 18. Americas Age Related Macular Degeneration (AMD) Market Size Market Share by Country in 2020
Figure 19. Americas Age Related Macular Degeneration (AMD) Market Size Market Share by Type in 2020
Figure 20. Americas Age Related Macular Degeneration (AMD) Market Size Market Share by Application in 2020
Figure 21. United States Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 22. Canada Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 23. Mexico Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 24. APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Regions in 2020
Figure 25. APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Type in 2020
Figure 26. APAC Age Related Macular Degeneration (AMD) Market Size Market Share by Application in 2020
Figure 27. China Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 28. Japan Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 29. Korea Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 30. Southeast Asia Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 31. India Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 32. Australia Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 33. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Countries in 2020
Figure 34. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Type in 2020
Figure 35. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Application in 2020
Figure 36. Germany Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 37. France Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 38. UK Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 39. Italy Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 40. Russia Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 41. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Region in 2020
Figure 42. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Type in 2020
Figure 43. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Application in 2020
Figure 44. Egypt Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 45. South Africa Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 46. Israel Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 47. Turkey Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 48. GCC Countries Age Related Macular Degeneration (AMD) Market Size Growth 2016-2021 ($ Millions)
Figure 49. Americas Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 50. APAC Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 51. Europe Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 52. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 53. United States Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 54. Canada Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 55. Mexico Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 56. Brazil Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 57. China Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 58. Japan Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 59. Korea Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 60. Southeast Asia Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 61. India Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 62. Australia Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 63. Germany Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 64. France Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 65. UK Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 66. Italy Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 67. Russia Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 68. Spain Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 69. Egypt Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 70. South Africa Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 71. Israel Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 72. Turkey Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Figure 73. GCC Countries Age Related Macular Degeneration (AMD) Market Size 2021-2026 ($ Millions)
Reason to Buy
- Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Medical Devices & Consumables Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets